Russia's Tax Increase on Nicotine E-Cigarette Liquid Expected to Bring 10 Billion Rubles in Revenue

Nov.24.2023
Russia's Tax Increase on Nicotine E-Cigarette Liquid Expected to Bring 10 Billion Rubles in Revenue
Russia's Finance Ministry estimates that doubling the tax on nicotine e-cigarette liquid will bring in 10 billion rubles.

According to recent reports from TASS, the Russian Ministry of Finance has estimated that doubling the tax on nicotine e-cigarette liquid will result in a benefit of 10 billion rubles (approximately 800 million yuan).


Alexei Sazanov, Deputy Minister of Finance, stated during a full session of the federal commission, "We anticipate the benefits to be around 10 billion rubles. Currently, this tax rate essentially serves as a prohibition, and we believe it will help increase budget revenues while reducing the consumption of nicotine products." This was his response regarding the expected financial benefits of raising the tax rate on nicotine e-cigarette liquid.


Previously, the Federal Commission approved a tax increase on tobacco products starting in 2024.


According to recently passed legislation, the tax rates for cigarettes and cigars will increase in 2024 to 2,813 rubles per thousand units plus 16% of the calculated price, but not less than 3,820 rubles. In 2025, the tax rate for cigarettes will further rise to 2,926 rubles per thousand units, plus 16% of the calculated price (not less than 3,973 rubles). By 2026, the tax rate for cigarettes will be further increased to 3,043 rubles per thousand units, plus 16% of the calculated price (not less than 4,132 rubles).


Currently, the tax rate for cigarettes is set at 2603 rubles per thousand units, plus an additional 16% of the calculated price, with a minimum price of 3536 rubles.


Regarding the tax rates for nicotine e-cigarette liquid, it is projected that in 2024, the rate will be 42 rubles per milliliter. In 2025, it will increase to 44 rubles per milliliter, and in 2026, it will further rise to 46 rubles per milliliter.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria and Reynolds American announce launch of new smokeless tobacco products without FDA approval; anti-smoking advocates express concerns over potential impact on youth health
Altria and Reynolds American announce launch of new smokeless tobacco products without FDA approval; anti-smoking advocates express concerns over potential impact on youth health
Altria and Reynolds American are rolling out smoke-free products without FDA approval due to delays. They highlight that illegal e-cigarettes, with candy flavors, are gaining market share while legal products await approval. Altria will release a new nicotine pouch in select states, and Reynolds will launch a disposable e-cigarette. Advocates fear these unauthorized products may attract new users and harm youth.
Sep.01 by 2FIRSTS.ai
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
Malaysia’s policy think tank Datametrics Research and Information Sdn Bhd (DARE) cautions that state- or nationwide bans on e-cigarettes would fuel the illicit market, weaken investor confidence, reduce tax revenues, and cost jobs. DARE argues that authorities should prioritize consistent enforcement under existing laws rather than impose new prohibitions.
Sep.28 by 2FIRSTS.ai
Observation | As China’s Nicotine Pouch Supply Chain Cools, Market Focus Accelerates Abroad
Observation | As China’s Nicotine Pouch Supply Chain Cools, Market Focus Accelerates Abroad
China’s nicotine pouch sector saw a sharp decline in exhibitors and traffic. Insiders cite tighter regulation and rising overseas competition, with many firms turning to Europe, the U.S., and the Middle East, and some building factories in Indonesia for growth.
Aug.28 by 2FIRSTS.ai
BPOM Indonesia: Crackdown on Ketamine-Laced Vape Products
BPOM Indonesia: Crackdown on Ketamine-Laced Vape Products
Indonesia’s Food and Drug Monitoring Agency (BPOM) announced it will take strict enforcement action against vape products found to contain ketamine. BPOM Chief Taruna Ikrar emphasized that the agency’s focus is not whether the product is a cigarette or a vape, but whether it contains harmful substances. Recently, the National Narcotics Agency (BNN) has seized multiple cases of ketamine and other new psychoactive substances allegedly intended for vape use, highlighting the rapid spread of the pro
Aug.28 by 2FIRSTS.ai
Singapore PM: E-Cigarettes to Be Treated as a Drug Issue, With Tougher Penalties and Whole-of-Government Enforcement
Singapore PM: E-Cigarettes to Be Treated as a Drug Issue, With Tougher Penalties and Whole-of-Government Enforcement
Singapore Prime Minister Lawrence Wong has announced that the government will begin treating e-cigarettes as a “drug problem,” strengthening enforcement and imposing harsher penalties, including imprisonment, on those who sell e-cigarettes containing harmful substances. At the same time, a nationwide public education campaign will be launched.
Aug.18 by 2FIRSTS.ai
Product | Reaching 60,000 Puffs, Innokin Launches MVP 60K Kit in the UK
Product | Reaching 60,000 Puffs, Innokin Launches MVP 60K Kit in the UK
INNOKIN has recently launched the MVP 60K vape kit in the UK market. The kit includes a 1000mAh built-in battery and three "2+10" combo pods. The company claims a total of 60,000 puffs, and the product offers 9 different flavor combinations. The MVP 60K has been registered in the database of the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and is now available on the websites of several UK distributors.
Aug.21 by 2FIRSTS.ai